Welcome to Central Library, SUST

Bioactive Natural Products : (Record no. 65353)

MARC details
000 -LEADER
fixed length control field 06072cam a2200733Ii 4500
001 - CONTROL NUMBER
control field sulb-eb0033701
003 - CONTROL NUMBER IDENTIFIER
control field BD-SySUS
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20170713221415.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS
fixed length control field m o d
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr cnu|||unuuu
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 150126s2015 gw ob 001 0 eng d
040 ## - CATALOGING SOURCE
Original cataloging agency N$T
Language of cataloging eng
Description conventions rda
-- pn
Transcribing agency N$T
Modifying agency IDEBK
-- N$T
-- E7B
-- YDXCP
-- COO
-- RECBK
-- OCLCF
-- CUS
-- EBLCP
-- DEBSZ
-- UIU
-- DEBBG
-- CCO
-- BD-SySUS
066 ## - CHARACTER SETS PRESENT
Alternate G0 or G1 character set (S
019 ## -
-- 902417600
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9783527684410
Qualifying information electronic bk.
International Standard Book Number 3527684417
Qualifying information electronic bk.
International Standard Book Number 9783527684403
International Standard Book Number 3527684409
Canceled/invalid ISBN 9783527337941
Canceled/invalid ISBN 3527337946
International Standard Book Number 9781322776422
Qualifying information MyiLibrary
International Standard Book Number 1322776423
Qualifying information MyiLibrary
029 1# - OTHER SYSTEM CONTROL NUMBER (OCLC)
OCLC library identifier DEBSZ
System control number 43187512X
OCLC library identifier DEBBG
System control number BV043397474
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)900723990
Canceled/invalid control number (OCoLC)902417600
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number QD415
072 #7 - SUBJECT CATEGORY CODE
Subject category code SCI
Subject category code subdivision 013040
Source bisacsh
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 547/.7
Edition number 23
049 ## - LOCAL HOLDINGS (OCLC)
Holding library MAIN
245 00 - TITLE STATEMENT
Title Bioactive Natural Products :
Remainder of title Chemistry and Biology /
Statement of responsibility, etc. edited by Goutam Brahmachari.
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Place of production, publication, distribution, manufacture Weinheim, Germany :
Name of producer, publisher, distributor, manufacturer Wiley-VCH,
Date of production, publication, distribution, manufacture, or copyright notice 2015.
300 ## - PHYSICAL DESCRIPTION
Extent 1 online resource (xxxiv, 507 pages)
336 ## - CONTENT TYPE
Content type term text
Content type code txt
Source rdacontent
337 ## - MEDIA TYPE
Media type term computer
Media type code c
Source rdamedia
338 ## - CARRIER TYPE
Carrier type term online resource
Carrier type code cr
Source rdacarrier
588 0# - SOURCE OF DESCRIPTION NOTE
Source of description note Vendor-supplied metadata.
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc Includes bibliographical references and index.
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note Bioactive Natural Products; Contents; Foreword; Preface; About the Editor; List of Contributors; Chapter 1 An Overview; 1.1 Introduction; 1.2 An Overview of the Book; 1.2.1 Chapter 2; 1.2.2 Chapter 3; 1.2.3 Chapter 4; 1.2.4 Chapter 5; 1.2.5 Chapter 6; 1.2.6 Chapter 7; 1.2.7 Chapter 8; 1.2.8 Chapter 9; 1.2.9 Chapter 10; 1.2.10 Chapter 11; 1.2.11 Chapter 12; 1.2.12 Chapter 13; 1.2.13 Chapter 14; 1.2.14 Chapter 15; 1.2.15 Chapter 16; 1.2.16 Chapter 17; 1.3 Concluding Remarks; Chapter 2 Use of Chemical Genomics to Investigate the Mechanism of Action for Inhibitory Bioactive Natural Compounds.
Formatted contents note 2.1 Introduction: Antibiotic Resistance and the Use of Natural Products as a Source for Novel Antimicrobials2.2 Chemical Genetics and Genomics; 2.3 Development of GDA Technology; 2.3.1 The Use of Gene Deletion Arrays (GDAs) to Investigate MOA; 2.3.2 Chemical Genetic Interactions; 2.3.3 Quantifying Genetic and Chemical Genetic Interactions; 2.3.4 Data Analysis; 2.3.5 Platforms for Chemical Genomic GDA Studies; 2.3.6 Why Screen Natural Products in GDAs?; 2.3.7 Successful Applications of GDA Technology; 2.4 Concluding Remarks; Abbreviations; References.
Linkage 880-01
Formatted contents note Chapter 4 Immunosuppressants: Remarkable Microbial Products4.1 Introduction; 4.2 Discovery; 4.3 Mode of Action; 4.4 Biosynthesis; 4.4.1 Acetate, Propionate, Butyrate, Methionine, and Valine as Precursors of the Macrolide Rings of Sirolimus, Ascomycin, and Tacrolimus; 4.4.2 Pipecolate Moiety of the Macrolide Ring of Sirolimus, Ascomycin, and Tacrolimus; 4.4.3 The Final Step in Biosynthesis of Ascomycins and Tacrolimus; 4.4.4 Formation of the Substituted Cyclohexyl Moiety of Sirolimus, Tacrolimus, and Ascomycins; 4.4.5 Biosynthesis of Cyclosporin; 4.5 Genetics and Strain Improvement.
Formatted contents note 4.6 Fermentation and Nutritional Studies4.7 Other Activities of Immunosuppressants; 4.8 Concluding Remarks; Acknowledgments; References; Chapter 5 Activators and Inhibitors of ADAM-10 for Management of Cancer and Alzheimer's Disease; 5.1 Introduction to ADAM Family of Enzymes; 5.2 ADAM-10 Structure and Physiological Roles; 5.3 Pathological Significance; 5.3.1 Modulating ADAM Activity in Neurodegeneration; 5.3.2 ADAM-10 in Cancer Pathology; 5.4 ADAM-10 as Potential Drug Target; 5.5 Synthetic Inhibitors of ADAM-10; 5.6 Natural Products as Activators and Inhibitors for ADAM-10.
520 ## - SUMMARY, ETC.
Summary, etc. Natural compounds, which have evolved their function over millions of years, are often more efficient than man-made compounds if a specific biological activity is needed, e.g. as an enzyme inhibitor or as a toxin to kill a cancer cell. This book comprising of sixteen technical chapters, highlights the chemical and biological aspects of potential natural products with an intention of unravelling their pharmaceutical applicability in modern drug discovery processes. Key features: Covers the synthesis, semi-synthesis and also biosynthesis of potentially bioactive natural productsFeatures chemi.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Natural products.
Topical term or geographic name as entry element Biochemistry.
Topical term or geographic name as entry element SCIENCE / Chemistry / Organic
Source of heading or term bisacsh
Topical term or geographic name as entry element Biochemistry.
Source of heading or term fast
Authority record control number (OCoLC)fst00831961
Topical term or geographic name as entry element Natural products.
Source of heading or term fast
Authority record control number (OCoLC)fst01034390
655 #4 - INDEX TERM--GENRE/FORM
Genre/form data or focus term Electronic books.
Genre/form data or focus term Electronic books.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Brahmachari, Goutam,
Relator term editor.
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Relationship information Print version:
Main entry heading Brahmachari, Goutam.
Title Bioactive Natural Products : Chemistry and Biology.
Place, publisher, and date of publication Hoboken : Wiley, ©2015
International Standard Book Number 9783527337941
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="http://onlinelibrary.wiley.com/book/10.1002/9783527684403">http://onlinelibrary.wiley.com/book/10.1002/9783527684403</a>
Public note Wiley Online Library [Free Download only for SUST IP]
880 8# - ALTERNATE GRAPHIC REPRESENTATION
Linkage 505-01/(S
a Chapter 3 High-Throughput Drug Screening Based on Cancer Signaling in Natural Product Screening3.1 Introduction; 3.2 Cancer Signaling Pathways with Their Own Drug Screening Assays in HTS; 3.2.1 β-Galactosidase Enzyme Complementation Assays for EGFR Signaling Drug Screening; 3.2.2 Fluorescence Superquenching Assays for PI3Ks Signaling Drug Screening; 3.2.3 TOP Flash Reporter Gene Assays for Wnt Signaling Drug Screening; 3.2.4 Luciferase Reporter Gene Assays for STATs Signaling Drug Screening; 3.3 Concluding Remarks; Abbreviations; References.
938 ## -
-- EBL - Ebook Library
-- EBLB
-- EBL4042558
-- EBSCOhost
-- EBSC
-- 942565
-- Ingram Digital eBook Collection
-- IDEB
-- cis30551321
-- ebrary
-- EBRY
-- ebr11011142
-- YBP Library Services
-- YANK
-- 12261767
-- Recorded Books, LLC
-- RECE
-- rbeEB00596213
-- EBL - Ebook Library
-- EBLB
-- EBL1896077
-- YBP Library Services
-- YANK
-- 11632403
-- YBP Library Services
-- YANK
-- 12679644
994 ## -
-- 92
-- DG1

No items available.